GENINUS Inc. Logo

GENINUS Inc.

AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.

389030 | KO

Overview

Corporate Details

ISIN(s):
KR7389030008
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로 70 4층, 5층(문정동, 케이디유타워), 송파구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Geninus Inc. is a biotechnology company specializing in genomic analysis for precision medicine. The company develops and provides solutions based on single-cell analysis, spatial multi-omics, and AI-driven platforms to deliver genetic insights for personalized treatment and disease prevention. Its core offerings include IntelliMed™, a clinical genomics service; MEDINSIGHT™, an AI-powered digital pathology solution for mapping transcriptomes; and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. Geninus supports pharmaceutical and clinical partners through services like biomarker and target discovery, patient stratification, Next-Generation Sequencing (NGS), and cancer genome companion diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 73.6 KB
2025-05-22 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제1회차 CB)
Korean 5.6 KB
2025-05-19 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 97.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.9 KB
2025-03-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-03-24 00:00
Related Party Transaction
[기재정정]타인에대한채무보증결정
Korean 23.5 KB
2025-03-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-17 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 436.9 KB
2025-03-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-03-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 142.9 KB

Automate Your Workflow. Get a real-time feed of all GENINUS Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENINUS Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENINUS Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea
230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050

Talk to a Data Expert

Have a question? We'll get back to you promptly.